{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:09:08Z","timestamp":1786115348871,"version":"build-2736575974"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cpet.2026.06.012","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T02:24:27Z","timestamp":1785983067000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Applications of FDG-PET Imaging in the Management of Patients with Hepatobiliary and Pancreatic Tumors"],"prefix":"10.1016","author":[{"given":"Chakshine","family":"Shiva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kowshik","family":"Vengadesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abass","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cpet.2026.06.012_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11605-023-05591-2","article-title":"Clinical implications of FDG-PET in pancreatic ductal adenocarcinoma patients treated with neoadjuvant therapy","volume":"27","author":"Ikenaga","year":"2023","journal-title":"J Gastrointest Surg"},{"issue":"9","key":"10.1016\/j.cpet.2026.06.012_bib2","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.21037\/qims-22-1420","article-title":"The application of 18F-FDG PET\/CT imaging for human hepatocellular carcinoma: a narrative review","volume":"13","author":"Yao","year":"2023","journal-title":"Quant Imag Med Surg"},{"issue":"3","key":"10.1016\/j.cpet.2026.06.012_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cpet.2015.03.001","article-title":"FDG PET\/CT in pancreatic and hepatobiliary carcinomas: value to patient management and patient outcomes","volume":"10","author":"Parikh","year":"2015","journal-title":"Pet Clin"},{"key":"10.1016\/j.cpet.2026.06.012_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1636566","article-title":"Evaluation of the efficacy of 18F-FDG PET-CT combined with CT in detecting lymph node metastasis in liver cancer","volume":"15","author":"Yu","year":"2025","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.cpet.2026.06.012_bib5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.itjm.2010.03.001","article-title":"Recent applications of nuclear medicine in diagnostics (I part)","volume":"4","author":"Treglia","year":"2010","journal-title":"Ital J Med"},{"key":"10.1016\/j.cpet.2026.06.012_bib6","article-title":"F-18 FDG PET\/CT imaging in normal variants, pitfalls and artifacts in the abdomen and pelvis","volume":"1","author":"Vangu","year":"2022","journal-title":"Front Nucl Med"},{"issue":"8","key":"10.1016\/j.cpet.2026.06.012_bib7","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.21037\/qims-2025-196","article-title":"Correlation between dual-time-point 18F-FDG PET\/CT imaging and pathological grade in hepatocellular carcinoma","volume":"15","author":"Xiao","year":"2025","journal-title":"Quant Imag Med Surg"},{"issue":"7","key":"10.1016\/j.cpet.2026.06.012_bib8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s12149-025-02045-4","article-title":"Analysis of the best time-point for 18F-FDG PET\/CT delayed imaging in patients of small colorectal cancer liver metastasis with hypothyroidism based on diagnostic efficacy and image standardized uptake values","volume":"39","author":"Pei","year":"2025","journal-title":"Ann Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2026.06.012_bib9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2214\/AJR.12.8930","article-title":"Dual\u2013time-point FDG PET\/CT for the evaluation of pediatric tumors","volume":"200","author":"Costantini","year":"2013","journal-title":"Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.cpet.2026.06.012_bib10","first-page":"1424","article-title":"Usefulness of 18F-FDG PET\/CT and MultiphasemCT in the Differentidl Diagnosis df Hepatocellhlar Carcinoma cnd Combined Hcpatocellhlar Carcinoma-carcinoma-crcinoma","volume":"81","author":"Park","year":"2020","journal-title":"Taehan Yongsang Uihakhoe Chi"},{"issue":"32","key":"10.1016\/j.cpet.2026.06.012_bib11","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.3748\/wjg.v25.i32.4682","article-title":"Positron-emission tomography for hepatocellular carcinoma: current status and future prospects","volume":"25","author":"Lu","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cpet.2026.06.012_bib12","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.4103\/jcrt.jcrt_1144_25","article-title":"Comparative diagnostic efficacy of 18F-FDG and FAPI PET\/CT in primary liver cancers: a systematic review and meta-analysis","volume":"21","author":"Wang","year":"2025","journal-title":"J Cancer Res Ther"},{"issue":"5","key":"10.1016\/j.cpet.2026.06.012_bib13","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1572-0241.2007.01710.x","article-title":"Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging","volume":"103","author":"Kim","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cpet.2026.06.012_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/247693","article-title":"Diagnostic accuracy of Fluorine-18-Fluorodeoxyglucose positron emission tomography in the evaluation of the primary tumor in patients with cholangiocarcinoma: a meta-analysis","volume":"2014","author":"Annunziata","year":"2014","journal-title":"BioMed Res Int"},{"issue":"1","key":"10.1016\/j.cpet.2026.06.012_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.gassur.2003.10.003","article-title":"Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma","volume":"8","author":"Anderson","year":"2004","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.cpet.2026.06.012_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jamcollsurg.2007.07.002","article-title":"18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer","volume":"206","author":"Corvera","year":"2008","journal-title":"J Am Coll Surg"},{"issue":"10","key":"10.1016\/j.cpet.2026.06.012_bib17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/BF02984683","article-title":"Distinguishing benign from malignant gallbladder wall thickening using FDG-PET","volume":"20","author":"Oe","year":"2006","journal-title":"Ann Nucl Med"},{"issue":"7","key":"10.1016\/j.cpet.2026.06.012_bib18","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ejso.2014.03.016","article-title":"Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis","volume":"40","author":"Rijkers","year":"2014","journal-title":"Eur J Surg Oncol EJSO"},{"key":"10.1016\/j.cpet.2026.06.012_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.668697","article-title":"The value of 18F-FDG PET\/CT in diagnosing pancreatic lesions: comparison with CA19-9, enhanced CT or enhanced MR","volume":"8","author":"Huang","year":"2021","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.cpet.2026.06.012_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","article-title":"Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma","volume":"18","author":"Llovet","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.cpet.2026.06.012_bib21","article-title":"Hepatocellular carcinoma: epidemiology, diagnosis and treatment","volume":"7","author":"Mauro","year":"2025","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.cpet.2026.06.012_bib22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40644-020-00356-5","article-title":"Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with small hepatocellular carcinoma treated by radiofrequency ablation","volume":"20","author":"Ida","year":"2020","journal-title":"Cancer Imaging"},{"issue":"3","key":"10.1016\/j.cpet.2026.06.012_bib23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.23736\/S1824-4785.17.02994-6","article-title":"Imaging of primary liver tumors with positron-emission tomography","volume":"61","author":"Haug","year":"2017","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.cpet.2026.06.012_bib24","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00259-019-04638-4","article-title":"Hypoxia-induced modulation of glucose transporter expression impacts 18F-fluorodeoxyglucose PET-CT imaging in hepatocellular carcinoma","volume":"47","author":"Xia","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.cpet.2026.06.012_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/000313480306900208","article-title":"The Role of [18 F]Fluorodeoxyglucose Positron Emission Tomography Imaging in the Evaluation of Hepatocellular Carcinoma","volume":"69","author":"Wudel","year":"2003","journal-title":"Am Surg"},{"issue":"10","key":"10.1016\/j.cpet.2026.06.012_bib26","first-page":"1811","article-title":"In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET","volume":"36","author":"Torizuka","year":"1995","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1016\/j.cpet.2026.06.012_bib27","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1007\/s00259-017-3764-7","article-title":"Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection","volume":"44","author":"Lee","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"10.1016\/j.cpet.2026.06.012_bib28","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00259-004-1602-1","article-title":"Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography","volume":"31","author":"Lee","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.cpet.2026.06.012_bib29","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1111\/j.1572-0241.1999.01544.x","article-title":"Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma","volume":"94","author":"Trojan","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cpet.2026.06.012_bib30","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2967\/jnumed.106.036673","article-title":"Dual-tracer PET\/CT imaging in evaluation of metastatic hepatocellular carcinoma","volume":"48","author":"Ho","year":"2007","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1016\/j.cpet.2026.06.012_bib31","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.ejrad.2011.08.004","article-title":"18F-FDG PET or PET\/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: a systematic review and meta-analysis","volume":"81","author":"Lin","year":"2012","journal-title":"Eur J Radiol"},{"issue":"7","key":"10.1016\/j.cpet.2026.06.012_bib32","doi-asserted-by":"crossref","first-page":"736","DOI":"10.7150\/thno.8725","article-title":"The prognostic value of 18F-FDG PET\/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE)","volume":"4","author":"Ma","year":"2014","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.cpet.2026.06.012_bib33","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3904\/kjim.2015.30.3.308","article-title":"Use of 18F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization","volume":"30","author":"Kim","year":"2015","journal-title":"Korean J Intern Med"},{"issue":"45","key":"10.1016\/j.cpet.2026.06.012_bib34","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v20.i45.17132","article-title":"Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma","volume":"20","author":"Han","year":"2014","journal-title":"World J Gastroenterol WJG"},{"issue":"2","key":"10.1016\/j.cpet.2026.06.012_bib35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cllc.2016.07.001","article-title":"Prognostic significance of FDG uptake of bone marrow on PET\/CT in patients with non\u2013small-cell lung cancer after curative surgical resection","volume":"18","author":"Lee","year":"2017","journal-title":"Clin Lung Cancer"},{"issue":"6","key":"10.1016\/j.cpet.2026.06.012_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.hpb.2018.10.007","article-title":"18F-FDG PET\/CT predicts microvascular invasion and early recurrence after liver resection for hepatocellular carcinoma: a prospective observational study","volume":"21","author":"Lim","year":"2019","journal-title":"HPB"},{"key":"10.1016\/j.cpet.2026.06.012_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.108828","article-title":"Preoperative PET-CT is useful for predicting recurrent extrahepatic metastasis of hepatocellular carcinoma after resection","volume":"124","author":"Morio","year":"2020","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.cpet.2026.06.012_bib38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijsu.2019.07.035","article-title":"FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study","volume":"69","author":"Ling","year":"2019","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.cpet.2026.06.012_bib39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000503577","article-title":"18F-fluorodeoxyglucose uptake in hepatocellular carcinoma as a useful predictor of an extremely rapid response to lenvatinib","volume":"9","author":"Kawamura","year":"2020","journal-title":"Liver Cancer"},{"issue":"3","key":"10.1016\/j.cpet.2026.06.012_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3857\/roj.2015.33.3.179","article-title":"Prognostic value of pretreatment 18F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma","volume":"33","author":"Jo","year":"2015","journal-title":"Radiat Oncol J"},{"issue":"2","key":"10.1016\/j.cpet.2026.06.012_bib41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.crad.2014.09.020","article-title":"Value of 18F-FDG PET\/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE","volume":"70","author":"Song","year":"2015","journal-title":"Clin Radiol"},{"issue":"10","key":"10.1016\/j.cpet.2026.06.012_bib42","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00432-009-0584-6","article-title":"Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China","volume":"135","author":"Fan","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2026.06.012_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jhbp.412","article-title":"Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study","volume":"24","author":"Takada","year":"2017","journal-title":"J Hepato-Biliary-Pancreat Sci"},{"issue":"5","key":"10.1016\/j.cpet.2026.06.012_bib44","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1159\/000544966","article-title":"18F-FDG PET\/CT predicts the prognosis of patients with hepatocellular carcinoma undergoing liver transplantation","volume":"14","author":"Zheng","year":"2025","journal-title":"Liver Cancer"},{"issue":"11","key":"10.1016\/j.cpet.2026.06.012_bib45","first-page":"5105","article-title":"Feasibility of 18F-fluorodeoxyglucose positron-emission tomography for preoperative evaluation of biliary tract cancer","volume":"32","author":"Yamada","year":"2012","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.cpet.2026.06.012_bib46","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1097\/RLU.0b013e318266f402","article-title":"The clinical value of dual-time point 18F-FDG PET\/CT for differentiating extrahepatic cholangiocarcinoma from benign disease","volume":"38","author":"Choi","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2026.06.012_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4166\/kjg.2013.62.4.227","article-title":"Primary tumor maximum standardized uptake value measured on18 F-Fluorodeoxyglucose positron emission tomography-computed tomography is a prognostic value for survival in bile duct and gallbladder cancer","volume":"62","author":"Lee","year":"2013","journal-title":"Korean J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cpet.2026.06.012_bib48","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/j.semnuclmed.2025.06.011","article-title":"The value of FAPI PET\/CT in cholangiocarcinoma and pancreatic cancer: an update","volume":"55","author":"Pabst","year":"2025","journal-title":"Semin Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2026.06.012_bib49","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s13244-013-0268-2","article-title":"Clinical impact of FDG PET-CT on management decisions for patients with primary biliary tumours","volume":"4","author":"Albazaz","year":"2013","journal-title":"Insights Imaging"},{"issue":"11","key":"10.1016\/j.cpet.2026.06.012_bib50","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.3390\/diagnostics12112889","article-title":"Comparison of conventional imaging and 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in the diagnostic accuracy of staging in patients with intrahepatic cholangiocarcinoma","volume":"12","author":"Nishioka","year":"2022","journal-title":"Diagnostics"},{"issue":"35","key":"10.1016\/j.cpet.2026.06.012_bib51","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020932","article-title":"Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography\/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: a meta-analysis","volume":"99","author":"Huang","year":"2020","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.cpet.2026.06.012_bib52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jhep.2006.03.009","article-title":"Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma","volume":"45","author":"Petrowsky","year":"2006","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.cpet.2026.06.012_bib53","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00268-017-4192-3","article-title":"Diagnostic and prognostic role of 18-FDG PET\/CT in the management of resectable biliary tract cancer","volume":"42","author":"Ma","year":"2018","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.cpet.2026.06.012_bib55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.rct.0000237811.88251.d7","article-title":"[F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma","volume":"31","author":"Jadvar","year":"2007","journal-title":"J Comput Assist Tomogr"},{"issue":"5","key":"10.1016\/j.cpet.2026.06.012_bib56","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1440-1746.2007.05173.x","article-title":"Usefulness of18 f-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas","volume":"23","author":"Moon","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cpet.2026.06.012_bib57","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jso.23476","article-title":"Ability of FDG-PET\/CT in the detection of gallbladder cancer","volume":"109","author":"Ramos-Font","year":"2014","journal-title":"J Surg Oncol"},{"issue":"6","key":"10.1016\/j.cpet.2026.06.012_bib58","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1053\/j.semnuclmed.2017.07.005","article-title":"FDG-PET\/CT in the postoperative period: utility, expected findings, complications, and pitfalls","volume":"47","author":"Garg","year":"2017","journal-title":"Semin Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2026.06.012_bib59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/MPA.0b013e3182550d77","article-title":"Utility of contrast-enhanced FDG-PET\/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence","volume":"42","author":"Asagi","year":"2013","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.cpet.2026.06.012_bib60","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1102\/1470-7330.2013.0035","article-title":"FDG-PET\/CT\u2013based restaging may alter initial management decisions and clinical outcomes in patients with locally advanced pancreatic carcinoma planned to undergo chemoradiotherapy","volume":"13","author":"Topkan","year":"2013","journal-title":"Cancer Imaging"},{"issue":"9","key":"10.1016\/j.cpet.2026.06.012_bib62","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.6004\/jnccn.2022.7041","article-title":"FDG-PET predicts neoadjuvant therapy response and survival in borderline resectable\/locally advanced pancreatic adenocarcinoma","volume":"20","author":"Abdelrahman","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2026.06.012_bib63","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2026.06.012_bib64","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13139-012-0151-y","article-title":"Prognostic value of SUVmax measured by Fluorine-18 fluorodeoxyglucose positron emission tomography with computed tomography in patients with pancreatic cancer","volume":"46","author":"Hwang","year":"2012","journal-title":"Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.cpet.2026.06.012_bib65","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.acra.2021.10.004","article-title":"Combined quantification of 18F-FDG and 68Ga-DOTATATE PET\/CT for prognosis in high-grade gastroenteropancreatic neuroendocrine neoplasms","volume":"29","author":"Lee","year":"2022","journal-title":"Acad Radiol"},{"issue":"4","key":"10.1016\/j.cpet.2026.06.012_bib66","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41416-022-02061-5","article-title":"Dual [68Ga] DOTATATE and [18F] FDG PET\/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score","volume":"128","author":"Chan","year":"2023","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.cpet.2026.06.012_bib67","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2967\/jnumed.109.068510","article-title":"Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET\/CT and Gd-EOB-DTPA\u2013enhanced MRI","volume":"51","author":"Donati","year":"2010","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2026.06.012_bib68","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3348\/kjr.2020.0689","article-title":"Additional value of integrated 18F-FDG PET\/MRI for evaluating biliary tract cancer: comparison with contrast-enhanced CT","volume":"22","author":"Yoo","year":"2021","journal-title":"Korean J Radiol"},{"issue":"2","key":"10.1016\/j.cpet.2026.06.012_bib69","first-page":"202","article-title":"Clinical oncologic applications of PET\/MRI: a new horizon","volume":"4","author":"Partovi","year":"2014","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.cpet.2026.06.012_bib70","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10334-012-0344-5","article-title":"PET\u2013MR imaging using a tri-modality PET\/CT\u2013MR system with a dedicated shuttle in clinical routine","volume":"26","author":"Veit-Haibach","year":"2013","journal-title":"Magn Reson Mater Phys Biol Med"},{"issue":"3","key":"10.1016\/j.cpet.2026.06.012_bib71","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.semnuclmed.2008.02.001","article-title":"Positron emission tomography\/magnetic resonance imaging: the next generation of multimodality imaging?","volume":"38","author":"Pichler","year":"2008","journal-title":"Semin Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2026.06.012_bib72","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3390\/ph18040522","article-title":"Fibroblast activation protein inhibitor (FAPI)-based theranostics","volume":"18","author":"Serumula","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.cpet.2026.06.012_bib73","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s13139-017-0500-y","article-title":"Radiomics in oncological PET\/CT: clinical applications","volume":"52","author":"Lee","year":"2018","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2026.06.012_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.crad.2025.107167","article-title":"Radiomics of hepatopancreatobiliary cancer diagnosis, management, and future prospects","volume":"92","author":"Koku","year":"2026","journal-title":"Clin Radiol"},{"issue":"3","key":"10.1016\/j.cpet.2026.06.012_bib75","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1053\/j.semnuclmed.2022.01.002","article-title":"Total-body PET\/CT - First clinical experiences and future perspectives","volume":"52","author":"Ng","year":"2022","journal-title":"Semin Nucl Med"},{"issue":"13","key":"10.1016\/j.cpet.2026.06.012_bib76","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015064","article-title":"Prognostic values of 18F-FDG PET\/CT metabolic parameters and clinical figures in locally advanced pancreatic cancer underwent chemotherapy combined with stereotactic body radiation therapy","volume":"98","author":"Zhang","year":"2019","journal-title":"Medicine (Baltim)"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859826000659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859826000659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T02:24:36Z","timestamp":1785983076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859826000659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":74,"alternative-id":["S1556859826000659"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2026.06.012","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applications of FDG-PET Imaging in the Management of Patients with Hepatobiliary and Pancreatic Tumors","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2026.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}